DO + CO AG/ AT0000818802 /
2024-05-13 8:00:22 AM | Chg. +3.60 | Volume | Bid4:41:37 PM | Ask4:41:37 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
148.80EUR | +2.48% | 0 Turnover: 0.00 |
151.00Bid Size: 30 | 151.60Ask Size: 30 | 1.48 bill.EUR | 0.66% | 43.95 |
GlobeNewswire
4:06 PM
Is Squarespace's $44 Per Share Sale Price Fair? Johnson Fistel, LLP Investigates Deal Terms
GlobeNewswire
3:30 PM
Impulse Dynamics Surpasses 10,000 Patients Benefiting From CCM® Therapy for Heart Failure
GlobeNewswire
3:30 PM
Hazelcast to Demonstrate Power of Unified Platform for Real-Time and AI Applications at the 2024 Gar...
GlobeNewswire
3:00 PM
Scilex Holding Company Provides Information to Scilex Stockholders Regarding Manipulative and Naked ...
GlobeNewswire
3:00 PM
Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2...
GlobeNewswire
2:50 PM
Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
2:36 PM
DEADLINE TOMORROW: Berger Montague Advises Innoviz Technologies Ltd. (NASDAQ: INVZ) Investors to Inq...
GlobeNewswire
2:30 PM
Significant and Sustained Improvements in Renal Function Reported for Adults with Chronic Hypoparath...
GlobeNewswire
2:30 PM
Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer
GlobeNewswire
2:30 PM
Abliva to Host Virtual KOL Event on KL1333 in Primary Mitochondrial Disease on May 21, 2024